Clinical significance of soluble-endoglin levels in systemic lupus erythematosus: possible association with anti-phospholipid syndrome

Structural and Functional Insights into Endoglin Ligand Recognition and Binding

(2012) Aaron Alt et al.   PLoS One

Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients

(2011) Ana M Blázquez-Medela et al.   BMC Medicine

Soluble Endoglin Specifically Binds Bone Morphogenetic Proteins 9 and 10 via Its Orphan Domain, Inhibits Blood Vessel Formation, and Suppresses Tumor Growth

(2011) Roselyne Castonguay et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Endothelial dysfunction in systemic lupus patients with low disease activity: evaluation by quantification and characterization of circulating endothelial microparticles, role of anti-endothelial cell antibodies

(2010) A. Duval et al.   RHEUMATOLOGY

Plasma soluble endoglin concentration in pre-eclampsia is associated with an increased impedance to flow in the maternal and fetal circulations

(2010) T. Chaiworapongsa et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Patients with antiphospholipid syndrome display endothelial perturbation

(2009) Massimo Cugno et al.   JOURNAL OF AUTOIMMUNITY

Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus

(2009) E Robak et al.   LUPUS

Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin

(2008) J. Wipff et al.   RHEUMATOLOGY